Research Article
Feasibility of a Microarray-Based Point-of-Care CYP2C19 Genotyping Test for Predicting Clopidogrel On-Treatment Platelet Reactivity
Table 2
Distributions of the CYP2C19 alleles, genotypes, and the predicted phenotypes.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The denotations are wt: wild type; UM: ultrarapid metabolizer; EM: extensive metabolizer; IM: intermediate metabolizer; and PM: poor metabolizer. |